ArticleBMC infectious diseases2026
Patterns of COVID-19 mortality during the second and third waves in Sri Lanka: a cross-sectional study from a tertiary care center.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION &
objectivesThe COVID-19 pandemic has claimed over 6.8 million lives globally, with varying impacts across different healthcare systems. Sri Lanka reported 591 and 15,800 deaths during the Second and Third Waves, respectively. This study investigates COVID-19 mortality patterns at a major tertiary care hospital in Sri Lanka during the pandemic, describing demographic characteristics of deaths, examining comorbidity patterns, and comparing deaths by vaccination status and treatment setting.
methodsA descriptive cross-sectional analysis was conducted using medical records of COVID-19-related deaths registered at Colombo North Teaching Hospital between November 2020 to December 2021. Among 1,269 deaths identified, 1,004 with complete clinical data were included in the analysis. Data were sourced from hospital records, supplemented by telephone interviews with family members for missing information, following informed consent. Statistical analyses included Mann-Whitney U tests and Pearson's Chi-squared tests for group comparisons.
resultsThere were 8,531 COVID-positive admissions during the study period, with 1,269 total recorded deaths (hospital mortality rate 14.9%); 1,004 deaths had complete data (79.1%) and were analysed. Median age of the study population was 72 years (IQR: 62-79, range: 19-99), with males constituting 57.2% of the cohort. Diabetes (61.6%), hypertension (36.9%), and coronary artery disease (14%) were the predominant comorbidities, with 37.2% having multiple comorbidities. COVID-19 pneumonia was the primary cause of death (83%). Most deaths (78.3%) occurred among unvaccinated individuals, while a smaller proportion (21.7%) occurred among those who had received at least one vaccine dose. Unvaccinated individuals were older, had longer hospital stays, and exhibited more severe symptoms compared to their vaccinated counterparts.
conclusionsMost deaths occurred among older adults and individuals with diabetes or hypertension. Strengthening vaccination outreach and clinical management of high-risk groups remains important. The lower proportion of vaccinated individuals observed among the deceased is notable; however, further population-level data are required to formally evaluate vaccine effectiveness. These descriptive findings underscore the need to prioritise high-risk populations in vaccination campaigns. These findings provide guidance for strengthening pandemic preparedness in resource-constrained settings, with potential applications across similar healthcare systems globally. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.